Tech Company Financing Transactions
Accelerated Technologies Funding Round
Giza Capital and Oxford Bioscience Partners joined a $32 million Series B funding round for Accelerated Technologies. The funding round was announced on 1/6/2003.
Transaction Overview
Company Name
Announced On
1/6/2003
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series B
Investors
Giza Capital (Avi Molcho)
Oxford Bioscience Partners (Jeffrey Barnes)
Proceeds Purpose
The funding will allow ATI to significantly expand its portfolio of projects and affiliates.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
301 Perimeter Center North 500
Atlanta, GA 30346
USA
Atlanta, GA 30346
USA
Phone
Website
Email Address
Overview
ATI is recognized as the leader in the rapid prototyping industry.The company has achieved this status through its experience, capacity, contributions to the industry, and, most importantly, customer satisfaction. ATI goes beyond just giving you parts. Our team of experts provides guidance to ensure parts are designed to deliver optimum performance and efficient assembly.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yuval Binur
Browse more venture capital transactions:
Prev: 1/6/2003: Neterion venture capital transaction
Next: 1/6/2003: Vascular Architects venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs